Newsletter Current page: 7

ESG investing in practice After explaining the topic in principle in Parts 1 and 2 of the series “ESG Investing” and showing how ESG investing is anchored throughout at SHS, today we describe two examples from the SHS portfolio. The “S” in the abbreviation ESG investing stands for “social”. This refers to social goals that […]

The world’s first jaw surgery with a bone incision using the CARLO® laser system from AOT was performed at the Paracelsus Clinic in Munich on 14 May 2021. Prof. Dr. Dr. med. Jürgens, who co-developed the robot-controlled laser surgical system, removed the bone layer by layer – without contact – using a laser during the […]

Surgical services are one of the major cost factors in everyday hospital life. Patients expect excellent results from surgery, and payers expect efficient interventions. It is no secret that there are sometimes considerable differences in quality from clinic to clinic. The Dutch company Incision, in which SHS has a stake, has set itself the goal […]

The high-tech company Crystal GmbH produces and processes diffusion-joined laser crystals, substrates for thin-film applications and optical components, among other things. In the field of crystal processing, Crystal is one of the leading suppliers and an important supplier to the medical technology industry. SHS invested in Crystal from its Fund II and is now handing […]

Dipl.-Ing. Marcus Raguse joined the management team of SHS portfolio company Novo Klinik-Service GmbH in May 2021. Novo offers medical aids and medical technology solutions. The graduate engineer brings with him a great deal of experience and know-how in the healthcare sector and, together with Ulrich Frick, who has been Managing Director since January 2021, […]

The company c-LEcta is one of the world’s leading biotech companies in the field of enzyme production. More than 200 customers in 40 countries, including well-known pharmaceutical companies, rely on the enzyme products from Leipzig. 2020 was a successful year for c-LEcta, in which the 10 million euro mark in turnover was broken for the […]

With the appointment of Dr. Alan Levy as Chairman of the Board, the Dutch growth company Salvia BioElectronics brings profound life science expertise and decades of experience to the team. Dr Levy has successfully exited four out of five early-stage healthcare companies and also sits on the board of Intuitive Surgical. Salvia develops electromedical neurostimulation […]

Dentist appointment 14,000 years ago Regular visits to the dentist are part of our natural health routines throughout the year, even if not every appointment in the dental chair is equally pleasant. But we should not complain, but feel privileged, as a look at the history of dentistry shows. It begins about 14,000 years ago […]

An interview with Dr Hanno Kühn, Chief Investment Officer (CIO) and head of apoBank’s institutional investment business, and Hubertus Leonhardt, Managing Director and partner of SHS Gesellschaft für Beteiligungsmanagement mbH. As the largest cooperative primary bank in Germany, apoBank is the number one financial services provider in the health care sector. Its business activities include […]

Despite the Corona pandemic, the high-tech company Tyromotion GmbH reports considerable success. Tyromotion develops state-of-the-art rehabilitation devices, among others for MS patients and stroke patients. Thanks to state-of-the-art robotics, sensor technology and virtual reality, the rehabilitation process becomes more intensive and the patient sees successes more quickly. The concept also convinced customers in Australia, where […]

Neuro Event Labs Oy is a leading healthtech company in the field of AI-based diagnosis and monitoring of epilepsy patients. Now the SHS portfolio company announces an extensive cooperation with Filadelfia Epilepsy Hospital in Dianalund. The renowned specialist clinic for epilepsy patients in western Denmark will use the AI-based diagnostic tool Nelli Pro on all […]

The successful specialty pharmaceutical company AMW GmbH is expanding its management team and bringing experience and leadership to its new CEO, Dr. Konstantin Petropoulus. With his many years of expertise, the molecular biologist with an MBA is to help strengthen AMW’s global presence. In addition, Dr. Petropoulus will expand the drug delivery system pipeline with […]